Gamma Ray Collimators

Gamma Ray Collimators Market Outlook

The global gamma ray collimators market is projected to reach USD 2.5 billion by 2035, growing at a CAGR of 5.8% from 2025 to 2035. This growth can be attributed to the rising demand for advanced imaging technologies in nuclear medicine and the increasing application of gamma ray collimators in various sectors such as industrial applications, homeland security, and astrophysics. Factors such as the growing research activities in nuclear physics and the increasing investments in medical imaging technologies are also contributing to the expansion of this market. Moreover, the aging population and the rising prevalence of chronic diseases are further driving the demand for gamma ray collimators, as they are essential components in medical imaging devices, notably in positron emission tomography (PET) and single photon emission computed tomography (SPECT).

Growth Factor of the Market

The gamma ray collimators market is bolstered by several key growth factors that enhance its trajectory. One of the primary drivers is the continuous technological advancements in medical imaging that necessitate high-precision instruments like gamma ray collimators. Furthermore, the rising incidence of cancer and cardiovascular diseases has led to an increased demand for effective diagnostic tools, including nuclear imaging systems. Additionally, the expansion of research activities in various scientific fields, including astrophysics and homeland security, is propelling the market forward. The growing awareness regarding the benefits of early diagnosis and personalized medicine also plays a significant role in driving the gamma ray collimators market, as healthcare providers seek advanced imaging modalities to improve patient outcomes. Furthermore, collaborative efforts among healthcare providers, educational institutions, and research organizations are fostering innovation and development in this sector.

Key Highlights of the Market

• Significant growth projected with a CAGR of 5.8% from 2025 to 2035.
• Increased demand for advanced imaging technologies in nuclear medicine.
• Rising applications in various sectors, including industrial and homeland security.
• Technological advancements enhancing the precision of gamma ray collimators.
• Collaborations and partnerships driving innovation in gamma ray collimation technology.

By Product Type

Single Pinhole Collimators:

Single pinhole collimators are among the most commonly used types of collimators in the gamma ray collimators market. They are characterized by their simplicity and effectiveness in producing high-resolution images in nuclear medicine applications, particularly in SPECT imaging. The ability to focus gamma rays from a single point source allows for better spatial resolution, making these collimators ideal for imaging small organs or tumors. The increasing adoption of SPECT due to its diagnostic accuracy is contributing to the growth of this segment. Furthermore, the affordability and ease of use of single pinhole collimators are driving their demand, especially in smaller medical facilities and research institutions where cost-effective solutions are favored.

Multi-Pinhole Collimators:

Multi-pinhole collimators offer enhanced imaging capabilities by utilizing multiple pinholes to capture gamma rays from various directions simultaneously. This design enables higher sensitivity and improved spatial resolution compared to single pinhole collimators, making them particularly suitable for dynamic imaging and small animal studies. The multi-pinhole technology is gaining traction in nuclear medicine for applications such as functional imaging and the assessment of physiological processes. As researchers and clinicians look for more efficient and reliable methods to obtain comprehensive imaging data, the multi-pinhole collimator segment is anticipated to witness robust growth in the coming years.

Parallel-Hole Collimators:

Parallel-hole collimators are widely utilized in nuclear medicine due to their versatility and effectiveness in various imaging applications. These collimators feature a series of parallel holes that allow gamma rays to pass through while rejecting scattered radiation, resulting in clearer and more accurate images. They are particularly effective in whole-body imaging and can be found in the majority of gamma cameras used in clinical settings. The robustness and adaptability of parallel-hole collimators make them a top choice for medical facilities, contributing to their steady demand in the market. With ongoing advancements in collimation technology, improvements in design and efficiency are expected to further enhance the growth prospects of this segment.

Focusing Collimators:

Focusing collimators are designed to concentrate gamma rays onto a specific detection area, thereby enhancing the sensitivity and improving image quality. These collimators are particularly beneficial when high-resolution images are required from small radioactive sources, making them useful in applications such as targeted radionuclide therapy and small animal imaging. The ability of focusing collimators to adapt to varying clinical scenarios makes them a valuable asset in the gamma ray collimators market. As research in molecular imaging and personalized medicine progresses, the demand for focusing collimators is expected to rise, driven by the need for precise and detailed imaging capabilities in nuclear medicine.

Converging Collimators:

Converging collimators are used to gather gamma rays from a broader area and converge them onto a detector, thereby improving the sensitivity and overall efficiency of imaging systems. These collimators are often employed in advanced imaging applications, including positron emission tomography (PET) and other nuclear imaging modalities. The ability to enhance image quality while reducing the effects of scattering makes converging collimators highly sought after in both clinical and research environments. With the increasing focus on advanced diagnostics and the growing prevalence of nuclear medicine, the segment of converging collimators is poised for significant growth in the gamma ray collimators market.

By Application

Nuclear Medicine:

Nuclear medicine is a primary application area for gamma ray collimators, where they play a crucial role in imaging techniques such as SPECT and PET. The ability of these collimators to enhance image resolution and reduce scatter significantly impacts diagnostic accuracy and treatment planning. With the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, the demand for innovative imaging solutions in nuclear medicine is rapidly growing. As healthcare providers increasingly adopt nuclear imaging for better disease management, the gamma ray collimators specific to this application are expected to see substantial growth in the coming years.

Astrophysics:

In the field of astrophysics, gamma ray collimators are utilized to detect and analyze cosmic gamma rays emitted by astronomical sources. The precision and sensitivity of these collimators enable researchers to gain insights into high-energy astrophysical phenomena, including supernovae, black holes, and neutron stars. The growing interest in space exploration and the continuous advancements in telescope technology are driving the demand for gamma ray collimators in astrophysical applications. As international space agencies and research organizations invest in sophisticated observational programs, the role of gamma ray collimators in astrophysics is expected to expand, contributing to the overall growth of the market.

Homeland Security:

In the realm of homeland security, gamma ray collimators are deployed for the detection of radioactive materials and monitoring of nuclear radiation. These collimators are critical in ensuring national security by preventing illicit trafficking of nuclear materials and enhancing border security measures. The increasing geopolitical tensions and the need for robust security protocols are fueling investments in advanced detection systems, thereby driving the demand for gamma ray collimators in this sector. As government agencies and defense organizations prioritize safety and security measures, the application of gamma ray collimators in homeland security is expected to witness significant growth.

Industrial Applications:

Gamma ray collimators also play a vital role in various industrial applications, including non-destructive testing and quality control in manufacturing processes. The ability of these collimators to provide accurate measurements and inspections ensures compliance with safety regulations and enhances the reliability of industrial operations. As industries seek to adopt advanced technologies for quality assurance and risk management, the demand for gamma ray collimators in industrial applications is projected to grow steadily. The increasing emphasis on safety standards and environmental regulations across multiple sectors is likely to further propel the market for gamma ray collimators in industrial contexts.

Research & Development:

Research and development activities across various scientific fields, including physics, biology, and engineering, leverage gamma ray collimators for advanced experimental setups and imaging techniques. These collimators enable researchers to study particle interactions, nuclear reactions, and other phenomena with high precision. The growing investment in scientific research and the increasing collaboration between academic institutions and industry are driving the demand for gamma ray collimators in R&D settings. As new discoveries and innovations continue to emerge, the reliance on advanced imaging technologies, including gamma ray collimators, is expected to grow, further enhancing the market's expansion.

By Distribution Channel

Online Stores:

Online stores have become an increasingly popular distribution channel for gamma ray collimators due to their convenience and accessibility. The growth of e-commerce platforms allows customers to easily compare products, read reviews, and make informed purchasing decisions from the comfort of their homes. Online channels also provide manufacturers and suppliers with a broader reach, enabling them to access a global market. As healthcare facilities and research institutions seek efficient procurement processes, the preference for online purchasing of gamma ray collimators is likely to continue rising, thereby contributing to the overall market growth.

Medical Equipment Suppliers:

Medical equipment suppliers play a crucial role in distributing gamma ray collimators to healthcare facilities and institutions. These suppliers often have established relationships with manufacturers and are equipped to provide technical support and guidance to customers. The expertise of medical equipment suppliers in understanding the specific needs of healthcare providers enables them to offer tailored solutions, enhancing customer satisfaction. As the demand for advanced medical imaging technologies continues to rise, the segment of medical equipment suppliers is expected to see steady growth, underscoring their importance in the gamma ray collimators market.

Specialty Stores:

Specialty stores focusing on medical imaging equipment serve as an essential distribution channel for gamma ray collimators, offering a curated selection of products tailored to the needs of specific clientele. These specialty retailers provide knowledgeable staff who can guide customers in selecting the appropriate collimators based on their unique requirements. Additionally, specialty stores often host demonstrations and provide hands-on experience, allowing potential buyers to assess the products before making a purchase. As institutions increasingly seek expert advice and personalized service, the importance of specialty stores in the gamma ray collimators market is expected to grow.

Direct Sales:

Direct sales strategies employed by manufacturers enable them to establish close relationships with customers, facilitating a better understanding of their needs and preferences. This approach allows manufacturers to offer customized solutions, training, and support, fostering customer loyalty. Direct sales channels are particularly important for high-value products such as gamma ray collimators, where expert knowledge and technical assistance are critical. Additionally, manufacturers can receive immediate feedback from customers, further enhancing product development and innovation. As the market for gamma ray collimators expands, the direct sales approach is anticipated to remain a key component of successful business strategies.

Others:

The “Others” category includes various distribution channels such as distributors, resellers, and procurement agencies that facilitate the availability of gamma ray collimators in the market. These channels can be particularly useful for reaching niche markets or specific customer segments that may not be covered by traditional distribution methods. The diversity of distribution channels ensures that gamma ray collimators are accessible to a wide range of customers, from large hospitals to small laboratories and research institutions. As the demand for gamma ray collimators continues to grow, these alternative distribution channels will play an essential role in meeting customer needs effectively.

By Material Type

Tungsten:

Tungsten is a widely used material in the manufacturing of gamma ray collimators due to its high density and excellent radiation shielding properties. The ability of tungsten to absorb gamma radiation effectively enhances the performance of collimators, resulting in improved image quality and accuracy. Additionally, tungsten's durability and resistance to corrosion make it an ideal choice for long-term applications in medical and industrial settings. As the demand for high-quality imaging solutions continues to rise, the segment of tungsten-based gamma ray collimators is anticipated to grow steadily, catering to the needs of various applications.

Lead:

Lead has traditionally been used in the production of gamma ray collimators due to its exceptional shielding capabilities against gamma radiation. The high atomic number of lead makes it an effective material for reducing radiation exposure to both patients and healthcare professionals. As a result, lead-based collimators have been widely employed in nuclear medicine, particularly in SPECT imaging applications. However, increasing awareness regarding the environmental and health concerns related to lead exposure has led to a growing demand for alternative materials. Despite this, lead remains a significant player in the gamma ray collimators market, particularly for applications where its efficacy is unmatched.

Brass:

Brass is often utilized in gamma ray collimators for its favorable mechanical properties and corrosion resistance. While not as dense as tungsten or lead, brass offers a balance of durability and functionality, making it suitable for specific applications where weight and ease of handling are critical. The use of brass in collimator design allows for the creation of lightweight and portable imaging devices, which is particularly important in mobile healthcare settings or field research. As the demand for versatile and user-friendly collimation solutions continues to grow, the segment of brass-based gamma ray collimators is likely to expand.

Aluminum:

Aluminum is increasingly being explored as a material for gamma ray collimators due to its lightweight nature and cost-effectiveness. Although aluminum does not offer the same level of radiation shielding as heavier materials, its low weight makes it ideal for applications where portability and ease of use are paramount. Researchers are focusing on optimizing aluminum collimators to enhance their performance while maintaining their lightweight characteristics. As the market shifts towards more flexible and accessible imaging solutions, aluminum-based gamma ray collimators are expected to gain traction, particularly in research and development settings.

Copper:

Copper is occasionally used in gamma ray collimators, primarily due to its excellent thermal conductivity and performance in various imaging applications. While not a primary material for collimation, copper can enhance the overall design of gamma ray collimators by improving heat dissipation and ensuring optimal operating conditions. The adoption of copper in collimator design is more common in specialized applications where its unique properties can be leveraged effectively. As innovations in gamma ray collimation technology continue, the application of copper is expected to see increased exploration, particularly in high-performance imaging devices.

By Region

The regional analysis of the gamma ray collimators market reveals significant variations in demand and growth potential across different geographies. North America is currently the largest market for gamma ray collimators, accounting for approximately 40% of the global market share in 2025. The region is characterized by a strong presence of advanced healthcare facilities, ongoing research initiatives in nuclear medicine, and significant investments in medical imaging technologies. Furthermore, the increasing prevalence of chronic diseases in North America is contributing to the demand for effective diagnostic solutions, which in turn drives the growth of the gamma ray collimators market. The CAGR for the North American market is projected to be around 5.5% from 2025 to 2035.

Europe follows closely behind North America in terms of market share, making up about 30% of the global gamma ray collimators market. The region is witnessing a rise in the adoption of nuclear imaging technologies, particularly in countries like Germany, the UK, and France, where healthcare systems are increasingly investing in advanced diagnostic tools. Additionally, the growing emphasis on research and development in nuclear physics and astrophysics is propelling the demand for gamma ray collimators in Europe. The CAGR for the European market is estimated at 5.2%, indicating steady growth in the coming years. In contrast, the Asia Pacific region is expected to experience the highest growth rate, driven by increasing healthcare investments and the expansion of research initiatives in countries like China and India.

Opportunities

The gamma ray collimators market is poised for significant opportunities driven by technological advancements and increasing demand across various sectors. One prominent opportunity lies in the development of innovative collimation technologies that enhance image quality and reduce radiation exposure. As healthcare providers prioritize patient safety and seek more accurate diagnostic tools, manufacturers have the chance to invest in research and development to create next-generation gamma ray collimators. Additionally, the expansion of telemedicine and remote diagnostic services presents an opportunity for portable gamma ray collimation solutions that can be utilized in field settings or in-home care scenarios. By focusing on creating adaptable and versatile products, companies can tap into new market segments and cater to evolving customer needs.

Moreover, the growing interest in personalized medicine and tailored treatment approaches is opening new avenues for gamma ray collimators in research and development applications. As researchers continue to explore and innovate in the field of nuclear medicine, they require high-quality imaging solutions to support their studies. Collaborations between manufacturers and research institutions can lead to the development of specialized collimators that meet specific research requirements. The increasing focus on environmental sustainability also presents an opportunity for manufacturers to explore eco-friendly materials and designs in gamma ray collimators, aligning with global trends towards sustainability and responsible sourcing.

Threats

Despite the promising growth prospects of the gamma ray collimators market, several threats could potentially hinder its development trajectory. One significant threat is the increasing regulatory scrutiny surrounding the use of radiation in medical and industrial applications. Stricter regulations and guidelines could lead to higher compliance costs for manufacturers and potentially limit the adoption of certain collimation technologies. Additionally, the growing awareness of the health risks associated with radiation exposure may prompt healthcare providers to seek alternative diagnostic methods, which could reduce demand for gamma ray collimators in specific applications. To mitigate such threats, manufacturers must stay informed about regulatory changes and adapt their product offerings accordingly.

Another potential threat to the gamma ray collimators market is the rapid pace of technological advancement in alternative imaging modalities, such as MRI and CT scans, which may compete with traditional nuclear imaging techniques. As these technologies become more prevalent and accessible, they could overshadow the demand for gamma ray collimators. Furthermore, economic uncertainties and fluctuations in funding for healthcare and research initiatives may impact the overall growth of the market. Manufacturers must remain agile and innovate continuously to address these challenges and ensure their products remain relevant in an evolving landscape.

Competitor Outlook

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems Corporation
• Shimadzu Corporation
• Hitachi Medical Corporation
• Bruker Corporation
• Mirada Medical
• Mediso Medical Imaging Systems
• Biospace Lab
• Hologic, Inc.
• Naviscan, Inc.
• Digirad Corporation
• NeuroLogica Corp.
• Curium Pharma

The gamma ray collimators market is characterized by a competitive landscape, with various players striving to capture market share through innovation and strategic partnerships. Major companies such as GE Healthcare, Siemens Healthineers, and Philips Healthcare lead the market, leveraging their extensive experience in medical imaging and advanced technologies. These industry giants continuously invest in research and development to enhance their product offerings and address the evolving needs of healthcare providers. Their strong brand recognition and established distribution networks position them favorably to capitalize on the growing demand for gamma ray collimators.

In addition to the major players, several niche companies are making significant contributions to the gamma ray collimators market. Companies like Mediso Medical Imaging Systems and Naviscan, Inc. specialize in developing advanced imaging technologies tailored to specific applications in nuclear medicine and research. These players often focus on innovative designs and enhanced features that differentiate their products in a competitive market. Collaborations with research institutions and healthcare providers enable these companies to remain at the forefront of technological advancements, fostering growth and market penetration.

The competitive landscape is also influenced by the growing trend of mergers and acquisitions, as companies seek to expand their capabilities and access new markets. Strategic partnerships between manufacturers, research institutions, and healthcare organizations are becoming increasingly common, driving innovation and facilitating the development of cutting-edge gamma ray collimation technologies. As the gamma ray collimators market continues to evolve, successful players will need to adopt agile strategies, prioritize customer needs, and invest in sustainable practices to thrive amidst competition.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Biospace Lab
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Curium Pharma
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hologic, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Mirada Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Naviscan, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 NeuroLogica Corp.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Bruker Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Philips Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Digirad Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Shimadzu Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Siemens Healthineers
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Hitachi Medical Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Mediso Medical Imaging Systems
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Canon Medical Systems Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Gamma Ray Collimators Market, By Application
    • 6.1.1 Nuclear Medicine
    • 6.1.2 Astrophysics
    • 6.1.3 Homeland Security
    • 6.1.4 Industrial Applications
    • 6.1.5 Research & Development
  • 6.2 Gamma Ray Collimators Market, By Product Type
    • 6.2.1 Single Pinhole Collimators
    • 6.2.2 Multi-Pinhole Collimators
    • 6.2.3 Parallel-Hole Collimators
    • 6.2.4 Focusing Collimators
    • 6.2.5 Converging Collimators
  • 6.3 Gamma Ray Collimators Market, By Material Type
    • 6.3.1 Tungsten
    • 6.3.2 Lead
    • 6.3.3 Brass
    • 6.3.4 Aluminum
    • 6.3.5 Copper
  • 6.4 Gamma Ray Collimators Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Medical Equipment Suppliers
    • 6.4.3 Specialty Stores
    • 6.4.4 Direct Sales
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Gamma Ray Collimators Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Gamma Ray Collimators market is categorized based on

By Product Type

• Single Pinhole Collimators
• Multi-Pinhole Collimators
• Parallel-Hole Collimators
• Focusing Collimators
• Converging Collimators

By Application

• Nuclear Medicine
• Astrophysics
• Homeland Security
• Industrial Applications
• Research & Development

By Distribution Channel

• Online Stores
• Medical Equipment Suppliers
• Specialty Stores
• Direct Sales
• Others

By Material Type

• Tungsten
• Lead
• Brass
• Aluminum
• Copper

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems Corporation
• Shimadzu Corporation
• Hitachi Medical Corporation
• Bruker Corporation
• Mirada Medical
• Mediso Medical Imaging Systems
• Biospace Lab
• Hologic, Inc.
• Naviscan, Inc.
• Digirad Corporation
• NeuroLogica Corp.
• Curium Pharma